Efficacy and Safety of Non-invasive Brain Stimulation in Non-migraine Primary Headache Disorders: A Systematic Review and Meta-analysis.

Authors

Mohd Asif, Seetu Palo, Vishakha Jain, Shikha Yadav, Sujith Mathew, Goutham Thumati, Sai Krishna Tikka, Samir Kumar Praharaj

Published in

Annals of Indian Academy of Neurology. Oct 03, 2026. Epub Oct 03, 2026.

Abstract

Non-migraine primary headache disorders such as tension-type headache and cluster headache are often chronic and significantly impair quality of life, with limited effective treatment options. Non-invasive brain stimulation (NIBS) techniques, including repetitive transcranial magnetic stimulation (rTMS) and transcranial electrical stimulation (tES), have emerged as promising neuromodulatory therapies. This systematic review evaluated the effectiveness and safety of NIBS in reducing headache frequency and intensity in non-migraine primary headache disorders.
This review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. A systematic search of PubMed, Embase, Scopus, and Google Scholar was conducted up to February 25, 2025. Randomized controlled trials and non-randomized studies assessing NIBS modalities in non-migraine primary headache disorders were included. Primary outcomes were headache frequency, intensity, and adverse effects. Meta-analysis was performed using a random-effects model, with subgroup analyses and heterogeneity assessed using the I 2 statistic. This review was registered with PROSPERO (CRD420250651461).
Of 1,043 records screened, 14 studies ( N = 690) met the inclusion criteria, of which 9 were eligible for meta-analysis. NIBS significantly reduced headache severity [standardized mean difference (SMD) = -1.30; 95% confidence interval (CI): -2.03 to -0.57; P = 0.0005] and disability (SMD = -1.49; 95% CI: -2.41 to -0.57; P = 0.001). Subgroup analysis showed greater efficacy of rTMS compared with tES. Reduction in headache frequency was not statistically significant. Adverse events were mild and infrequent. Most studies had a moderate to high risk of bias.
NIBS, particularly rTMS, may be effective in reducing headache severity and disability in non-migraine primary headache disorders. However, further high-quality, large-scale studies are needed to establish its role in routine clinical practice.

PMID:
42831689
Bibliographic data and abstract were imported from PubMed on 05 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.